Predicting quality of life impairment in chronic schizophrenia from cognitive variables

Quality of Life Research

Volumn 16, Issue 6, 2007, Pages 929-937

  Ritsner, Michael S ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Neurocognitive functioning; Predicting; Quality of life; Schizophrenia

Indexed keywords

ADULT; ARTICLE; COGNITIVE DEFECT; DISEASE SEVERITY; EMOTIONAL STRESS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MOTOR PERFORMANCE; MULTIPLE REGRESSION; NEUROPSYCHOLOGICAL TEST; PATIENT ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SCHIZOPHRENIA; VISUAL ADAPTATION;

ADOLESCENT; ADULT; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; ISRAEL; MALE; MIDDLE AGED; MODELS, PSYCHOLOGICAL; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF ASSESSMENT (PSYCHOLOGY); SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE;

EID: 34547486387     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-007-9195-3     Document Type: Article

References (41)

1. Testa, M. A., & Simonson, D. C. (1996). Assessment of quality-of-life outcomes. The New England Journal of Medicine, 334, 835-840.
2. Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA, 273, 59-65.
3. Ritsner, M. S. (2007). The distress/protection vulnerability model of the quality of life impairment syndrome: Current evidence and new directions for research. In M. S. Ritsner & A. G. Awad (Eds.), Quality of life impairment in Schizophrenia, mood and anxiety disorders. New perspectives on research and treatment (pp. 3-19). Springer.
4. Keefe, R. S., Bilder, R. M., Harvey, P. D., Davis, S. M., Palmer, B. W., Gold, J. M., Meltzer, H. Y., Green, M. F., Miller, D. D., Canive, J. M., Adler, L. W., Manschreck, T. C., Swartz, M., Rosenheck, R., Perkins, D. O., Walker, T. M., Stroup, T. S., McEvoy, J. P., & Lieberman, J. A. (2006). Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology, 31, 2033-2046.
5. Heslegrave, R. J., Awad, A. G., & Voruganti, L. N. (1997). The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia. Journal of Psychiatry and Neuroscience, 22, 235-243.
6. Addington, J., & Addington, D. (2002). Cognitive functioning in first-episode schizophrenia. Journal of Psychiatry and Neuroscience, 27, 188-192.
7. Kaiser, W. (2000). Cognitive effects of antipsychotics in schizophrenia and relationship to quality of life. British Journal of Psychiatry, 176, 92-93.
8. Aksaray, G., Oflu, S., Kaptanoglu, C., & Bal, C. (2002). Neurocognitive deficits and quality of life in outpatients with schizophrenia. Progress in Neuro-psychopharmacology & Biological Psychiatry, 26, 1217-1219.
9. Sota, T. L., & Heinrichs, R. W. (2004). Demographic, clinical, and neurocognitive predictors of quality of life in schizophrenia patients receiving conventional neuroleptics. Comprehensive Psychiatry, 45, 415-421.
10. Alptekin, K., Akvardar, Y., Kivircik Akdede, B. B., et al. (2005). Is quality of life associated with cognitive impairment in schizophrenia?. Progress in Neuro-psychopharmacology and Biological Psychiatry, 29, 239-244.
11. Wegener, S., Redoblado-Hodge, M. A., Lucas, S., et al. (2005). Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. The Australian and New Zealand Journal of Psychiatry, 39, 487-492.
12. Awad, A. G., Voruganti, L. N., & Heslegrave, R. J. A. (1997). Conceptual model of quality of life in schizophrenia: Description and preliminary drugs, relationships to objective psychopathology, quality of life, clinical validation. Quality of Life Research, 6, 21-26.
13. Ritsner, M., Modai, I., Endicott, J., Rivkin, O., Nechamkin, Y., Barak, P., Goldin, V., & Ponizovsky, A. (2000). Differences in quality of life domains, psychopathological and psychosocial factors in psychiatric patients. Journal of Clinical Psychiatry, 61, 880-889.
14. Ritsner, M., Gibel, A., & Ratner, Y. (2006). Determinants of changes in perceived quality of life in the course of Schizophrenia. Quality of Life Research, 15, 515-526.
15. Fitzgerald, P. B., Williams, C. L., Corteling, N., et al. (2001). Subject and observer-rated quality of life in schizophrenia. Acta Psychiatrica Scandinavica, 103, 387-392.
16. Heinrichs, D. W., Hanlon, T. E., & Carpenter, W. T. (1984). The Quality of Life Scale: An instrument for rating the schizophrenic deficit scale. Schizophrenia Bulletin, 10, 388-398.
17. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders. Washington, DC.
18. Endicott, J., Nee, J., Harrison, W., & Blumenthal, R. (1993). Quality of life enjoyment and satisfaction questionnaire: A new measure. Psychopharmacology Bulletin, 29, 321-326.
19. Ritsner, M., Modai, I., Kurs, R., et al. (2002). Subjective quality of life measurements in severe mental health patients: Measuring quality of life of psychiatric patients: Comparison two questionnaires. Quality Life Research, 11, 553-561.
20. Sahakian, B. J., & Owen, A. M. (1992). Computerized assessment in neuropsychiatry using CANTAB: Discussion paper. Journal of the Royal Society of Medicine, 85, 399-402.
21. Robbins, T. W., James, M., Owen, A. M., Sahakian, B. J., McInnes, L., & Rabbitt, P. (1994). Cambridge Neuropsychological Test Automated Battery (CANTAB): A factor analytic study of a large sample of normal elderly volunteers. Dementia, 5, 266-281.
22. Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261-276.
23. Ritsner, M., Rabinowitz, J., & Slyuzberg, M. (1995). The Talbieh Brief Distress Inventory: A brief instrument to measure psychological distress among immigrants. Comprehensive Psychiatry, 36, 448-453.
24. Chouinard, G., Ross-Chouinard, A., Annale, L., et al. (1980). Extrapyramidal Symptom Rating Scale. Canadian Journal of Neurological Sciences, 7, 233.
25. White, L., Harvey, P. D., Opler, L., Lindenmayer, J. P. & PANSS Study Group. (1997). Empirical assessment of the factorial structure of clinical symptoms in Schizophrenia. Psychopathology, 30, 263-274.
26. Ritsner, M., Modai, I., & Ponizovsky, A. (2002). The Talbieh brief distress inventory: Validation for use with psychiatric patients. Comprehensive Psychiatry, 2, 144-163.
27. Hintze, J. L., NCSS & PASS. (2001). Statistical system for Windows. User's guide. number cruncher statistical systems, number cruncher statistical systems, Kaysville. Utah. www.NCSS.com.
28. Awad, A. G., & Voruganti, L. N. (2004). Impact of atypical antipsychotics on quality of life in patients with schizophrenia. CNS Drugs, 18, 877-893.
29. Lambert, M., & Naber, D. (2004). Current issues in schizophrenia: Overview of patient acceptability, functioning capacity and quality of life. CNS Drugs, 2 (18 Suppl), 5-17.
30. Ritsner, M., & Kurs, R. (2006). Quality-of-life impairment in severe mental illness: Focus on Schizoaffective disorders. In William H. Murray (ed.), Schizoaffective disorder: New research. (pp. 69-107). NY: NOVA Publishers.
31. Erlenmeyer-Kimling, L., Rock, D., Roberts, S. A., Janal, M., Kestenbaum, C., Cornblatt, B., & Adamo, U. H. (2000). Gottesman II. Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: The New York High-Risk Project. The American Journal of Psychiatry, 157, 1416-1422.
32. Zalla, T., Joyce, C., Szoke, A., Schurhoff, F., Pillon, B., Komano, O., Perez-Diaz, F., Bellivier, F., Alter, C., Dubois, B., Rouillon, F., Houde, O'., & Leboyer, M. (2004). Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia. Psychiatry Research, 21, 207-217.
33. Hoff, A. L., Svetina, C., Maurizio, A. M., Crow, T. J., Spokes, K., & DeLisi, L. E. (2005). Familial cognitive deficits in schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 133, 43-49.
34. Saperstein, A. M., Fuller, R. L., Avila, M. T., Adami, H., McMahon, R. P., Thaker, G. K., & Gold, J. M. (2006). Spatial working memory as a cognitive endophenotype of schizophrenia: Assessing risk for pathophysiological dysfunction. Schizophrenia Bulletin, 32, 498-506.
35. Chen, W. J., & Faraone, S. V. (2000). Sustained attention deficits as markers of genetic susceptibility to schizophrenia. American Journal of Medical Genetics, 97, 52-57.
36. Liu, S. K., Chiu, C. H., Chang, C. J., Hwang, T. J., Hwu, H. G., & Chen, W. J. (2002). Deficits in sustained attention in schizophrenia and affective disorders: stable versus state-dependent markers. The American Journal of Psychiatry, 159, 975-982.
37. Bozikas, V. P., Andreou, C., Giannakou, M., Tonia, T., Anezoulaki, D., Karavatos, A., Fokas, K., & Kosmidis, M. H. (2005). Deficits in sustained attention in schizophrenia but not in bipolar disorder. Schizophrenia Research, 78, 225-233.
38. Stone, W. S., Faraone, S. V., Seidman, L. J., et al. (2001). Concurrent validation of schizotaxia: A pilot study. Biological Psychiatry, 50, 434-440.
39. Tsuang, M. T., Stone, W. S., Gamma, F., & Faraone, S. V. (2003). Schizotaxia: Current status and future directions. Current Psychiatry Reports, 5, 128-134.
40. Erickson, D. H., Beiser, M., Iacono, W. G., et al. (1989). The role of social relationships in the course of first-episode schizophrenia and affective psychosis. The American Journal of Psychiatry, 146, 1456-1461.
41. Bechdolf, A., Pukrop, R., Kohn, D., et al. (2005). Subjective quality of life in subjects at risk for a first episode of psychosis: A comparison with first episode schizophrenia patients and healthy controls. Schizophrenia Research, 79, 137-143.